首页 > 最新文献

Journal of Neurodevelopmental Disorders最新文献

英文 中文
Sleep disturbances are associated with greater healthcare utilization in children with autism spectrum disorder. 睡眠障碍与自闭症谱系障碍儿童使用更多医疗服务有关。
IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-06-07 DOI: 10.1186/s11689-024-09550-z
Shirley Solomon, Leena Elbedour, Gal Meiri, Analya Michaelovski, Yair Sadaka, Michal Ilan, Michal Faroy, Ilan Dinstein, Idan Menashe

Background: Sleep disturbances are frequently reported in children with autism spectrum disorder (ASD) and are associated with the severity of co-occurring symptoms. This study's aim was to examine the extent of healthcare utilization and clinical outcomes associated with sleep disturbances in children with ASD.

Study design: A retrospective, cross-sectional study of 541 children with ASD from the Azrieli National Center for Autism and Neurodevelopment Research (ANCAN) whose parents completed the Children's Sleep Habits Questionnaire (CSHQ). Children with a total CSHQ score ≥ 48 were defined as having sleep disturbances. Sociodemographic characteristics, ASD diagnostic measures, chronic co-occurring conditions, medication usage, hospitalizations, visits to the emergency room (ER), and visits to specialists were compared in ASD children with and without sleep disturbances. Multivariate logistic regression models were then used to assess the independent association of sleep disturbances with clinical characteristics and healthcare utilization.

Results: Of the 541 children with ASD, 257 (47.5%) had sleep disturbances. Children with sleep disturbances exhibited higher rates of multiple (≥ 3) co-occurring conditions (19.1% vs. 12.7%; p = 0.0414) and prescribed medications (45.5% vs. 32.7%; p = 0.0031) than other children. Finally, ASD children with sleep disturbances were 1.72 and 2.71 times more likely to visit the ER and be hospitalized than their counterparts (aOR = 1.72; 99%CI = 1.01-2.95; and aOR = 2.71; 99%CI = 1.10-6.67, respectively).

Conclusions: Our findings suggest that sleep disturbances are associated with greater healthcare utilization among children with ASD. Further studies could examine whether treating sleep disturbances in children with ASD yields additional clinical benefits beyond improvements in sleep.

背景:自闭症谱系障碍(ASD)儿童经常会出现睡眠障碍,而且睡眠障碍与并发症状的严重程度有关。本研究旨在探讨自闭症谱系障碍儿童中与睡眠障碍相关的医疗利用程度和临床结果:研究设计:一项回顾性横断面研究,研究对象是541名来自Azrieli国家自闭症和神经发育研究中心(ANCAN)的自闭症儿童,这些儿童的家长填写了儿童睡眠习惯问卷(CSHQ)。CSHQ 总分≥ 48 分的儿童被定义为有睡眠障碍。对有睡眠障碍和无睡眠障碍的 ASD 儿童的社会人口特征、ASD 诊断指标、慢性并发症、药物使用、住院、急诊室就诊和专科医生就诊情况进行了比较。然后使用多变量逻辑回归模型评估睡眠障碍与临床特征和医疗保健使用的独立关联:在 541 名 ASD 儿童中,有 257 名(47.5%)存在睡眠障碍。与其他儿童相比,有睡眠障碍的儿童同时患有多种(≥ 3 种)并发症(19.1% 对 12.7%;p = 0.0414)和服用处方药(45.5% 对 32.7%;p = 0.0031)的比例更高。最后,患有睡眠障碍的 ASD 儿童到急诊室就诊和住院的几率分别是其他儿童的 1.72 倍和 2.71 倍(aOR = 1.72;99%CI = 1.01-2.95;aOR = 2.71;99%CI = 1.10-6.67):我们的研究结果表明,睡眠障碍与 ASD 儿童使用更多医疗服务有关。进一步的研究可以探讨治疗 ASD 儿童的睡眠障碍是否会在改善睡眠之外带来更多临床益处。
{"title":"Sleep disturbances are associated with greater healthcare utilization in children with autism spectrum disorder.","authors":"Shirley Solomon, Leena Elbedour, Gal Meiri, Analya Michaelovski, Yair Sadaka, Michal Ilan, Michal Faroy, Ilan Dinstein, Idan Menashe","doi":"10.1186/s11689-024-09550-z","DOIUrl":"10.1186/s11689-024-09550-z","url":null,"abstract":"<p><strong>Background: </strong>Sleep disturbances are frequently reported in children with autism spectrum disorder (ASD) and are associated with the severity of co-occurring symptoms. This study's aim was to examine the extent of healthcare utilization and clinical outcomes associated with sleep disturbances in children with ASD.</p><p><strong>Study design: </strong>A retrospective, cross-sectional study of 541 children with ASD from the Azrieli National Center for Autism and Neurodevelopment Research (ANCAN) whose parents completed the Children's Sleep Habits Questionnaire (CSHQ). Children with a total CSHQ score ≥ 48 were defined as having sleep disturbances. Sociodemographic characteristics, ASD diagnostic measures, chronic co-occurring conditions, medication usage, hospitalizations, visits to the emergency room (ER), and visits to specialists were compared in ASD children with and without sleep disturbances. Multivariate logistic regression models were then used to assess the independent association of sleep disturbances with clinical characteristics and healthcare utilization.</p><p><strong>Results: </strong>Of the 541 children with ASD, 257 (47.5%) had sleep disturbances. Children with sleep disturbances exhibited higher rates of multiple (≥ 3) co-occurring conditions (19.1% vs. 12.7%; p = 0.0414) and prescribed medications (45.5% vs. 32.7%; p = 0.0031) than other children. Finally, ASD children with sleep disturbances were 1.72 and 2.71 times more likely to visit the ER and be hospitalized than their counterparts (aOR = 1.72; 99%CI = 1.01-2.95; and aOR = 2.71; 99%CI = 1.10-6.67, respectively).</p><p><strong>Conclusions: </strong>Our findings suggest that sleep disturbances are associated with greater healthcare utilization among children with ASD. Further studies could examine whether treating sleep disturbances in children with ASD yields additional clinical benefits beyond improvements in sleep.</p>","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"16 1","pages":"29"},"PeriodicalIF":4.9,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11157737/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probing a neural unreliability account of auditory sensory processing atypicalities in Rett Syndrome. 探究雷特综合征听觉感官处理非典型性的神经不可靠原因。
IF 4.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-06-03 DOI: 10.1186/s11689-024-09544-x
Tufikameni Brima, Shlomit Beker, Kevin D Prinsloo, John S Butler, Aleksandra Djukic, Edward G Freedman, Sophie Molholm, John J Foxe

Background: In the search for objective tools to quantify neural function in Rett Syndrome (RTT), which are crucial in the evaluation of therapeutic efficacy in clinical trials, recordings of sensory-perceptual functioning using event-related potential (ERP) approaches have emerged as potentially powerful tools. Considerable work points to highly anomalous auditory evoked potentials (AEPs) in RTT. However, an assumption of the typical signal-averaging method used to derive these measures is "stationarity" of the underlying responses - i.e. neural responses to each input are highly stereotyped. An alternate possibility is that responses to repeated stimuli are highly variable in RTT. If so, this will significantly impact the validity of assumptions about underlying neural dysfunction, and likely lead to overestimation of underlying neuropathology. To assess this possibility, analyses at the single-trial level assessing signal-to-noise ratios (SNR), inter-trial variability (ITV) and inter-trial phase coherence (ITPC) are necessary.

Methods: AEPs were recorded to simple 100 Hz tones from 18 RTT and 27 age-matched controls (Ages: 6-22 years). We applied standard AEP averaging, as well as measures of neuronal reliability at the single-trial level (i.e. SNR, ITV, ITPC). To separate signal-carrying components from non-neural noise sources, we also applied a denoising source separation (DSS) algorithm and then repeated the reliability measures.

Results: Substantially increased ITV, lower SNRs, and reduced ITPC were observed in auditory responses of RTT participants, supporting a "neural unreliability" account. Application of the DSS technique made it clear that non-neural noise sources contribute to overestimation of the extent of processing deficits in RTT. Post-DSS, ITV measures were substantially reduced, so much so that pre-DSS ITV differences between RTT and TD populations were no longer detected. In the case of SNR and ITPC, DSS substantially improved these estimates in the RTT population, but robust differences between RTT and TD were still fully evident.

Conclusions: To accurately represent the degree of neural dysfunction in RTT using the ERP technique, a consideration of response reliability at the single-trial level is highly advised. Non-neural sources of noise lead to overestimation of the degree of pathological processing in RTT, and denoising source separation techniques during signal processing substantially ameliorate this issue.

背景:在寻找量化雷特综合征(Rett Syndrome,RTT)神经功能的客观工具的过程中,使用事件相关电位(ERP)方法记录感觉-知觉功能已成为潜在的有力工具。大量研究表明,RTT 患者的听觉诱发电位(AEP)高度异常。然而,用于得出这些测量结果的典型信号平均法的一个假设是基本反应的 "静止性",即对每个输入的神经反应都是高度定型的。另一种可能性是,对重复刺激的反应在 RTT 中变化很大。如果是这样,这将极大地影响对潜在神经功能障碍假设的有效性,并可能导致对潜在神经病理的高估。为了评估这种可能性,有必要在单次试验水平上进行分析,评估信噪比(SNR)、试验间变异性(ITV)和试验间相位一致性(ITPC):对 18 名 RTT 和 27 名年龄匹配的对照组患者(年龄:6-22 岁)简单的 100 赫兹音调记录 AEP。我们采用了标准的 AEP 平均法,以及单次试验水平的神经元可靠性测量方法(即 SNR、ITV、ITPC)。为了从非神经噪声源中分离出信号携带成分,我们还采用了去噪源分离(DSS)算法,然后重复了可靠性测量:结果:在 RTT 参与者的听觉反应中观察到 ITV 大幅增加、信噪比降低和 ITPC 降低,这支持了 "神经不可靠 "的说法。DSS 技术的应用清楚地表明,非神经噪音源会导致高估 RTT 处理缺陷的程度。DSS 后,ITV 测量值大幅降低,以至于不再能检测到 RTT 和 TD 患者之间 DSS 前的 ITV 差异。在 SNR 和 ITPC 方面,DSS 大幅改善了 RTT 患者的估计值,但 RTT 和 TD 之间的显著差异仍然十分明显:结论:要利用 ERP 技术准确反映 RTT 神经功能障碍的程度,建议考虑单次试验水平的反应可靠性。非神经噪音源会导致高估 RTT 的病理处理程度,而信号处理过程中的去噪源分离技术可大大改善这一问题。
{"title":"Probing a neural unreliability account of auditory sensory processing atypicalities in Rett Syndrome.","authors":"Tufikameni Brima, Shlomit Beker, Kevin D Prinsloo, John S Butler, Aleksandra Djukic, Edward G Freedman, Sophie Molholm, John J Foxe","doi":"10.1186/s11689-024-09544-x","DOIUrl":"10.1186/s11689-024-09544-x","url":null,"abstract":"<p><strong>Background: </strong>In the search for objective tools to quantify neural function in Rett Syndrome (RTT), which are crucial in the evaluation of therapeutic efficacy in clinical trials, recordings of sensory-perceptual functioning using event-related potential (ERP) approaches have emerged as potentially powerful tools. Considerable work points to highly anomalous auditory evoked potentials (AEPs) in RTT. However, an assumption of the typical signal-averaging method used to derive these measures is \"stationarity\" of the underlying responses - i.e. neural responses to each input are highly stereotyped. An alternate possibility is that responses to repeated stimuli are highly variable in RTT. If so, this will significantly impact the validity of assumptions about underlying neural dysfunction, and likely lead to overestimation of underlying neuropathology. To assess this possibility, analyses at the single-trial level assessing signal-to-noise ratios (SNR), inter-trial variability (ITV) and inter-trial phase coherence (ITPC) are necessary.</p><p><strong>Methods: </strong>AEPs were recorded to simple 100 Hz tones from 18 RTT and 27 age-matched controls (Ages: 6-22 years). We applied standard AEP averaging, as well as measures of neuronal reliability at the single-trial level (i.e. SNR, ITV, ITPC). To separate signal-carrying components from non-neural noise sources, we also applied a denoising source separation (DSS) algorithm and then repeated the reliability measures.</p><p><strong>Results: </strong>Substantially increased ITV, lower SNRs, and reduced ITPC were observed in auditory responses of RTT participants, supporting a \"neural unreliability\" account. Application of the DSS technique made it clear that non-neural noise sources contribute to overestimation of the extent of processing deficits in RTT. Post-DSS, ITV measures were substantially reduced, so much so that pre-DSS ITV differences between RTT and TD populations were no longer detected. In the case of SNR and ITPC, DSS substantially improved these estimates in the RTT population, but robust differences between RTT and TD were still fully evident.</p><p><strong>Conclusions: </strong>To accurately represent the degree of neural dysfunction in RTT using the ERP technique, a consideration of response reliability at the single-trial level is highly advised. Non-neural sources of noise lead to overestimation of the degree of pathological processing in RTT, and denoising source separation techniques during signal processing substantially ameliorate this issue.</p>","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"16 1","pages":"28"},"PeriodicalIF":4.1,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11149250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrapartum exposure to synthetic oxytocin, maternal BMI, and neurodevelopmental outcomes in children within the ECHO consortium 产前接触合成催产素、孕产妇体重指数和 ECHO 联合体中儿童的神经发育结果
IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-05-26 DOI: 10.1186/s11689-024-09540-1
Lisa Kurth, T. Michael O’Shea, Irina Burd, Anne L. Dunlop, Lisa Croen, Greta Wilkening, Ting-ju Hsu, Stephan Ehrhardt, Arvind Palanisamy, Monica McGrath, Marie L. Churchill, Daniel Weinberger, Marco Grados, Dana Dabelea
Synthetic oxytocin (sOT) is frequently administered during parturition. Studies have raised concerns that fetal exposure to sOT may be associated with altered brain development and risk of neurodevelopmental disorders. In a large and diverse sample of children with data about intrapartum sOT exposure and subsequent diagnoses of two prevalent neurodevelopmental disorders, i.e., attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), we tested the following hypotheses: (1) Intrapartum sOT exposure is associated with increased odds of child ADHD or ASD; (2) associations differ across sex; (3) associations between intrapartum sOT exposure and ADHD or ASD are accentuated in offspring of mothers with pre-pregnancy obesity. The study sample comprised 12,503 participants from 44 cohort sites included in the Environmental Influences on Child Health Outcomes (ECHO) consortium. Mixed-effects logistic regression analyses were used to estimate the association between intrapartum sOT exposure and offspring ADHD or ASD (in separate models). Maternal obesity (pre-pregnancy BMI ≥ 30 kg/m2) and child sex were evaluated for effect modification. Intrapartum sOT exposure was present in 48% of participants. sOT exposure was not associated with increased odds of ASD (adjusted odds ratio [aOR] 0.86; 95% confidence interval [CI], 0.71–1.03) or ADHD (aOR 0.89; 95% CI, 0.76–1.04). Associations did not differ by child sex. Among mothers with pre-pregnancy obesity, sOT exposure was associated with lower odds of offspring ADHD (aOR 0.72; 95% CI, 0.55–0.96). No association was found among mothers without obesity (aOR 0.97; 95% CI, 0.80–1.18). In a large, diverse sample, we found no evidence of an association between intrapartum exposure to sOT and odds of ADHD or ASD in either male or female offspring. Contrary to our hypothesis, among mothers with pre-pregnancy obesity, sOT exposure was associated with lower odds of child ADHD diagnosis.
合成催产素(sOT)经常在分娩过程中使用。有研究担心,胎儿接触 sOT 可能与大脑发育改变和神经发育障碍风险有关。在一个大型、多样化的儿童样本中,我们获得了有关产前暴露于 sOT 以及随后诊断出两种普遍存在的神经发育障碍(即:注意力缺陷多动障碍(AD))的数据、我们测试了以下假设:(1)产前暴露于 sOT 与儿童多动症或自闭症的几率增加有关;(2)不同性别之间的相关性不同;(3)母亲孕前肥胖的后代在产前暴露于 sOT 与多动症或自闭症之间的相关性更强。研究样本包括环境对儿童健康结果的影响(ECHO)联盟中 44 个队列研究点的 12,503 名参与者。研究采用混合效应逻辑回归分析来估算产前 sOT 暴露与后代多动症或 ASD 之间的关系(在不同的模型中)。对母亲肥胖(孕前体重指数≥ 30 kg/m2)和儿童性别进行了效应修正评估。48%的参与者在产前暴露于sOT。sOT暴露与ASD(调整后几率比[aOR]为0.86;95%置信区间[CI]为0.71-1.03)或ADHD(aOR为0.89;95%置信区间[CI]为0.76-1.04)的几率增加无关。儿童性别不同,相关性也不同。在孕前肥胖的母亲中,接触 sOT 可降低后代患多动症的几率(aOR 0.72;95% CI,0.55-0.96)。在没有肥胖症的母亲中没有发现相关性(aOR 0.97;95% CI,0.80-1.18)。在一个大型、多样化的样本中,我们没有发现产前暴露于 sOT 与男性或女性后代患多动症或 ASD 的几率之间存在关联的证据。与我们的假设相反,在孕前肥胖的母亲中,sOT 暴露与较低的儿童多动症诊断几率有关。
{"title":"Intrapartum exposure to synthetic oxytocin, maternal BMI, and neurodevelopmental outcomes in children within the ECHO consortium","authors":"Lisa Kurth, T. Michael O’Shea, Irina Burd, Anne L. Dunlop, Lisa Croen, Greta Wilkening, Ting-ju Hsu, Stephan Ehrhardt, Arvind Palanisamy, Monica McGrath, Marie L. Churchill, Daniel Weinberger, Marco Grados, Dana Dabelea","doi":"10.1186/s11689-024-09540-1","DOIUrl":"https://doi.org/10.1186/s11689-024-09540-1","url":null,"abstract":"Synthetic oxytocin (sOT) is frequently administered during parturition. Studies have raised concerns that fetal exposure to sOT may be associated with altered brain development and risk of neurodevelopmental disorders. In a large and diverse sample of children with data about intrapartum sOT exposure and subsequent diagnoses of two prevalent neurodevelopmental disorders, i.e., attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), we tested the following hypotheses: (1) Intrapartum sOT exposure is associated with increased odds of child ADHD or ASD; (2) associations differ across sex; (3) associations between intrapartum sOT exposure and ADHD or ASD are accentuated in offspring of mothers with pre-pregnancy obesity. The study sample comprised 12,503 participants from 44 cohort sites included in the Environmental Influences on Child Health Outcomes (ECHO) consortium. Mixed-effects logistic regression analyses were used to estimate the association between intrapartum sOT exposure and offspring ADHD or ASD (in separate models). Maternal obesity (pre-pregnancy BMI ≥ 30 kg/m2) and child sex were evaluated for effect modification. Intrapartum sOT exposure was present in 48% of participants. sOT exposure was not associated with increased odds of ASD (adjusted odds ratio [aOR] 0.86; 95% confidence interval [CI], 0.71–1.03) or ADHD (aOR 0.89; 95% CI, 0.76–1.04). Associations did not differ by child sex. Among mothers with pre-pregnancy obesity, sOT exposure was associated with lower odds of offspring ADHD (aOR 0.72; 95% CI, 0.55–0.96). No association was found among mothers without obesity (aOR 0.97; 95% CI, 0.80–1.18). In a large, diverse sample, we found no evidence of an association between intrapartum exposure to sOT and odds of ADHD or ASD in either male or female offspring. Contrary to our hypothesis, among mothers with pre-pregnancy obesity, sOT exposure was associated with lower odds of child ADHD diagnosis.","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"469 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2024-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141153079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rescue of impaired blood-brain barrier in tuberous sclerosis complex patient derived neurovascular unit. 修复结节性硬化症复合体患者受损的血脑屏障衍生神经血管单元。
IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-05-23 DOI: 10.1186/s11689-024-09543-y
Jacquelyn A Brown, Shannon L Faley, Monika Judge, Patricia Ward, Rebecca A Ihrie, Robert Carson, Laura Armstrong, Mustafa Sahin, John P Wikswo, Kevin C Ess, M Diana Neely

Background: Tuberous sclerosis complex (TSC) is a multi-system genetic disease that causes benign tumors in the brain and other vital organs. The most debilitating symptoms result from involvement of the central nervous system and lead to a multitude of severe symptoms including seizures, intellectual disability, autism, and behavioral problems. TSC is caused by heterozygous mutations of either the TSC1 or TSC2 gene and dysregulation of mTOR kinase with its multifaceted downstream signaling alterations is central to disease pathogenesis. Although the neurological sequelae of the disease are well established, little is known about how these mutations might affect cellular components and the function of the blood-brain barrier (BBB).

Methods: We generated TSC disease-specific cell models of the BBB by leveraging human induced pluripotent stem cell and microfluidic cell culture technologies.

Results: Using microphysiological systems, we demonstrate that a BBB generated from TSC2 heterozygous mutant cells shows increased permeability. This can be rescued by wild type astrocytes or by treatment with rapamycin, an mTOR kinase inhibitor.

Conclusion: Our results demonstrate the utility of microphysiological systems to study human neurological disorders and advance our knowledge of cell lineages contributing to TSC pathogenesis and informs future therapeutics.

背景:结节性硬化综合征(TSC)是一种多系统遗传病,会在大脑和其他重要器官中引发良性肿瘤。最令人衰弱的症状是中枢神经系统受累,导致多种严重症状,包括癫痫发作、智力障碍、自闭症和行为问题。TSC是由TSC1或TSC2基因的杂合突变引起的,mTOR激酶的失调及其下游多方面的信号改变是疾病发病机制的核心。尽管该病的神经系统后遗症已被证实,但人们对这些突变可能如何影响细胞成分和血脑屏障(BBB)的功能却知之甚少:方法:我们利用人体诱导多能干细胞和微流体细胞培养技术生成了TSC疾病特异性血脑屏障细胞模型:结果:我们利用微生理学系统证明,由TSC2杂合突变细胞生成的BBB显示出通透性增加。这可以通过野生型星形胶质细胞或使用雷帕霉素(一种 mTOR 激酶抑制剂)治疗来缓解:我们的研究结果证明了微观生理学系统在研究人类神经系统疾病方面的实用性,并增进了我们对导致TSC发病机制的细胞系的了解,为未来的治疗提供了信息。
{"title":"Rescue of impaired blood-brain barrier in tuberous sclerosis complex patient derived neurovascular unit.","authors":"Jacquelyn A Brown, Shannon L Faley, Monika Judge, Patricia Ward, Rebecca A Ihrie, Robert Carson, Laura Armstrong, Mustafa Sahin, John P Wikswo, Kevin C Ess, M Diana Neely","doi":"10.1186/s11689-024-09543-y","DOIUrl":"10.1186/s11689-024-09543-y","url":null,"abstract":"<p><strong>Background: </strong>Tuberous sclerosis complex (TSC) is a multi-system genetic disease that causes benign tumors in the brain and other vital organs. The most debilitating symptoms result from involvement of the central nervous system and lead to a multitude of severe symptoms including seizures, intellectual disability, autism, and behavioral problems. TSC is caused by heterozygous mutations of either the TSC1 or TSC2 gene and dysregulation of mTOR kinase with its multifaceted downstream signaling alterations is central to disease pathogenesis. Although the neurological sequelae of the disease are well established, little is known about how these mutations might affect cellular components and the function of the blood-brain barrier (BBB).</p><p><strong>Methods: </strong>We generated TSC disease-specific cell models of the BBB by leveraging human induced pluripotent stem cell and microfluidic cell culture technologies.</p><p><strong>Results: </strong>Using microphysiological systems, we demonstrate that a BBB generated from TSC2 heterozygous mutant cells shows increased permeability. This can be rescued by wild type astrocytes or by treatment with rapamycin, an mTOR kinase inhibitor.</p><p><strong>Conclusion: </strong>Our results demonstrate the utility of microphysiological systems to study human neurological disorders and advance our knowledge of cell lineages contributing to TSC pathogenesis and informs future therapeutics.</p>","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"16 1","pages":"27"},"PeriodicalIF":4.9,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11112784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141087688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome. 佩兰-麦克德米综合征癫痫发作的临床、遗传和认知相关性。
IF 4.1 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-05-10 DOI: 10.1186/s11689-024-09541-0
Tess Levy, Jacob Gluckman, Paige M Siper, Danielle Halpern, Jessica Zweifach, Rajna Filip-Dhima, J Lloyd Holder, M Pilar Trelles, Kristina Johnson, Jonathan A Bernstein, Elizabeth Berry-Kravis, Craig M Powell, Latha Valluripalli Soorya, Audrey Thurm, Joseph D Buxbaum, Mustafa Sahin, Alexander Kolevzon, Siddharth Srivastava

Background: Phelan-McDermid syndrome (PMS) is a genetic neurodevelopmental disorder caused by SHANK3 haploinsufficiency and is associated with an increased risk for seizures. Previous literature indicates that around one third of individuals with PMS also have epilepsy or seizures, with a wide range of types and ages of onset. Investigating the impact of seizures on intellectual and adaptive functioning for PMS is a primary concern for caregivers and is important to understanding the natural history of this syndrome.

Methods: We report on results from 98 individuals enrolled in a prospective, longitudinal study. We detailed seizure frequency, type, and age of onset, and we analyzed seizure occurrence with best estimate IQ, adaptive functioning, clinical features, and genotype. We conducted multiple linear regression analyses to assess the relationship between the presence of seizures and the Vineland Adaptive Behavior Scale, Second Edition (VABS-II) Adaptive Behavior Composite score and the best estimate full-scale IQ. We also performed Chi-square tests to explore associations between seizure prevalence and genetic groupings. Finally, we performed Chi-square tests and t-tests to explore the relationship between seizures and demographic features, features that manifest in infancy, and medical features.

Results: Seizures were present in 41% of the cohort, and age of onset was widely variable. The presence of seizures was associated with significantly lower adaptive and intellectual functioning. Genotype-phenotype analyses were discrepant, with no differences in seizure prevalence across genetic classes, but with more genes included in deletions of participants with 22q13 deletions and seizures compared to those with 22q13 deletions and no seizures. No clinical associations were found between the presence of seizures and sex, history of pre- or neonatal complications, early infancy, or medical features. In this cohort, generalized seizures were associated with developmental regression, which is a top concern for PMS caregivers.

Conclusions: These results begin to eludicate correlates of seizures in individuals with PMS and highlight the importance of early seizure management. Importantly, presence of seizures was associated with adaptive and cognitive functioning. A larger cohort might be able to identify additional associations with medical features. Genetic findings suggest an increased capability to realize genotype-phenotype relationships when deletion size is taken into account.

背景:菲兰-麦克德米综合征(PMS)是一种由 SHANK3 单倍体缺乏引起的遗传性神经发育障碍,与癫痫发作风险增加有关。以往的文献表明,约有三分之一的 PMS 患者同时患有癫痫或癫痫发作,类型和发病年龄各不相同。调查癫痫发作对 PMS 患者智力和适应功能的影响是护理人员最关心的问题,对于了解该综合征的自然史也非常重要:我们报告了一项前瞻性纵向研究中 98 名患者的研究结果。我们详细介绍了癫痫发作频率、类型和发病年龄,并分析了癫痫发作与最佳估计智商、适应功能、临床特征和基因型的关系。我们进行了多元线性回归分析,以评估癫痫发作与维尼兰适应行为量表第二版(VABS-II)适应行为综合评分和最佳估计全面智商之间的关系。我们还进行了卡方检验,以探讨癫痫发作率与遗传分组之间的关联。最后,我们进行了卡方检验和 t 检验,以探讨癫痫发作与人口统计学特征、婴儿期表现特征和医学特征之间的关系:结果:41%的患者有癫痫发作,发病年龄差异很大。癫痫发作与较低的适应能力和智力相关。基因型-表型分析结果显示,不同基因类别的癫痫发作率没有差异,但与22q13缺失且无癫痫发作的患者相比,22q13缺失且有癫痫发作的患者的基因缺失率更高。没有发现癫痫发作与性别、产前或新生儿并发症病史、婴儿早期或医学特征有临床关联。在这个队列中,全身性癫痫发作与发育倒退有关,而发育倒退是早产儿护理人员最关心的问题:这些结果开始阐明 PMS 患者癫痫发作的相关性,并强调了早期癫痫发作管理的重要性。重要的是,癫痫发作与适应能力和认知功能相关。更大规模的队列可能会发现与医疗特征的其他关联。遗传学研究结果表明,如果考虑到基因缺失的大小,实现基因型与表型关系的能力就会提高。
{"title":"Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome.","authors":"Tess Levy, Jacob Gluckman, Paige M Siper, Danielle Halpern, Jessica Zweifach, Rajna Filip-Dhima, J Lloyd Holder, M Pilar Trelles, Kristina Johnson, Jonathan A Bernstein, Elizabeth Berry-Kravis, Craig M Powell, Latha Valluripalli Soorya, Audrey Thurm, Joseph D Buxbaum, Mustafa Sahin, Alexander Kolevzon, Siddharth Srivastava","doi":"10.1186/s11689-024-09541-0","DOIUrl":"10.1186/s11689-024-09541-0","url":null,"abstract":"<p><strong>Background: </strong>Phelan-McDermid syndrome (PMS) is a genetic neurodevelopmental disorder caused by SHANK3 haploinsufficiency and is associated with an increased risk for seizures. Previous literature indicates that around one third of individuals with PMS also have epilepsy or seizures, with a wide range of types and ages of onset. Investigating the impact of seizures on intellectual and adaptive functioning for PMS is a primary concern for caregivers and is important to understanding the natural history of this syndrome.</p><p><strong>Methods: </strong>We report on results from 98 individuals enrolled in a prospective, longitudinal study. We detailed seizure frequency, type, and age of onset, and we analyzed seizure occurrence with best estimate IQ, adaptive functioning, clinical features, and genotype. We conducted multiple linear regression analyses to assess the relationship between the presence of seizures and the Vineland Adaptive Behavior Scale, Second Edition (VABS-II) Adaptive Behavior Composite score and the best estimate full-scale IQ. We also performed Chi-square tests to explore associations between seizure prevalence and genetic groupings. Finally, we performed Chi-square tests and t-tests to explore the relationship between seizures and demographic features, features that manifest in infancy, and medical features.</p><p><strong>Results: </strong>Seizures were present in 41% of the cohort, and age of onset was widely variable. The presence of seizures was associated with significantly lower adaptive and intellectual functioning. Genotype-phenotype analyses were discrepant, with no differences in seizure prevalence across genetic classes, but with more genes included in deletions of participants with 22q13 deletions and seizures compared to those with 22q13 deletions and no seizures. No clinical associations were found between the presence of seizures and sex, history of pre- or neonatal complications, early infancy, or medical features. In this cohort, generalized seizures were associated with developmental regression, which is a top concern for PMS caregivers.</p><p><strong>Conclusions: </strong>These results begin to eludicate correlates of seizures in individuals with PMS and highlight the importance of early seizure management. Importantly, presence of seizures was associated with adaptive and cognitive functioning. A larger cohort might be able to identify additional associations with medical features. Genetic findings suggest an increased capability to realize genotype-phenotype relationships when deletion size is taken into account.</p>","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"16 1","pages":"25"},"PeriodicalIF":4.1,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11084001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex differences during development in cortical temporal processing and event related potentials in wild-type and fragile X syndrome model mice. 野生型和脆性 X 综合征模型小鼠大脑皮层时间处理和事件相关电位发育过程中的性别差异。
IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-05-08 DOI: 10.1186/s11689-024-09539-8
Katilynne Croom, Jeffrey A Rumschlag, Michael A Erickson, Devin Binder, Khaleel A Razak

Background: Autism spectrum disorder (ASD) is currently diagnosed in approximately 1 in 44 children in the United States, based on a wide array of symptoms, including sensory dysfunction and abnormal language development. Boys are diagnosed ~ 3.8 times more frequently than girls. Auditory temporal processing is crucial for speech recognition and language development. Abnormal development of temporal processing may account for ASD language impairments. Sex differences in the development of temporal processing may underlie the differences in language outcomes in male and female children with ASD. To understand mechanisms of potential sex differences in temporal processing requires a preclinical model. However, there are no studies that have addressed sex differences in temporal processing across development in any animal model of ASD.

Methods: To fill this major gap, we compared the development of auditory temporal processing in male and female wildtype (WT) and Fmr1 knock-out (KO) mice, a model of Fragile X Syndrome (FXS), a leading genetic cause of ASD-associated behaviors. Using epidural screw electrodes, we recorded auditory event related potentials (ERP) and auditory temporal processing with a gap-in-noise auditory steady state response (ASSR) paradigm at young (postnatal (p)21 and p30) and adult (p60) ages from both auditory and frontal cortices of awake, freely moving mice.

Results: The results show that ERP amplitudes were enhanced in both sexes of Fmr1 KO mice across development compared to WT counterparts, with greater enhancement in adult female than adult male KO mice. Gap-ASSR deficits were seen in the frontal, but not auditory, cortex in early development (p21) in female KO mice. Unlike male KO mice, female KO mice show WT-like temporal processing at p30. There were no temporal processing deficits in the adult mice of both sexes.

Conclusions: These results show a sex difference in the developmental trajectories of temporal processing and hypersensitive responses in Fmr1 KO mice. Male KO mice show slower maturation of temporal processing than females. Female KO mice show stronger hypersensitive responses than males later in development. The differences in maturation rates of temporal processing and hypersensitive responses during various critical periods of development may lead to sex differences in language function, arousal and anxiety in FXS.

背景:目前,美国每 44 名儿童中就有 1 名被诊断患有自闭症谱系障碍 (ASD),其症状多种多样,包括感官功能障碍和语言发育异常。男孩被诊断为自闭症的频率是女孩的 3.8 倍。听觉颞区处理对语言识别和语言发展至关重要。颞叶处理发育异常可能是导致 ASD 语言障碍的原因。颞叶处理发育过程中的性别差异可能是患有 ASD 的男女儿童在语言成果方面存在差异的原因。要了解时间处理过程中潜在的性别差异机制,需要一个临床前模型。然而,目前还没有任何研究涉及 ASD 动物模型在整个发育过程中时间处理的性别差异:为了填补这一重大空白,我们比较了雄性和雌性野生型(WT)小鼠和 Fmr1 基因敲除(KO)小鼠的听觉时间处理发育情况,后者是脆性 X 综合征(FXS)的模型,而脆性 X 综合征是 ASD 相关行为的主要遗传原因。我们使用硬膜外螺钉电极,通过噪声间隙听觉稳态反应(ASSR)范式,记录了清醒、自由活动的小鼠在幼年(出生后(p)21 和 p30)和成年(p60)时的听觉和额叶皮层的听觉事件相关电位(ERP)和听觉时间处理过程:结果表明,与 WT 小鼠相比,Fmr1 KO 小鼠的ERP 振幅在整个发育过程中都有所增强,其中成年雌性 KO 小鼠比成年雄性 KO 小鼠的增强幅度更大。在雌性KO小鼠的早期发育阶段(p21),额叶皮层(而非听觉皮层)出现了间隙-ASSR缺陷。与雄性 KO 小鼠不同,雌性 KO 小鼠在 p30 阶段表现出与 WT 小鼠类似的颞叶处理能力。成年雌雄小鼠均无颞叶处理缺陷:这些结果表明,Fmr1 KO 小鼠的时间处理和超敏反应的发育轨迹存在性别差异。雄性 KO 小鼠的时间处理成熟比雌性慢。雌性 KO 小鼠在发育后期比雄性表现出更强的超敏反应。在发育的各个关键时期,时间处理和超敏反应的成熟速度存在差异,这可能会导致FXS患者在语言功能、唤醒和焦虑方面存在性别差异。
{"title":"Sex differences during development in cortical temporal processing and event related potentials in wild-type and fragile X syndrome model mice.","authors":"Katilynne Croom, Jeffrey A Rumschlag, Michael A Erickson, Devin Binder, Khaleel A Razak","doi":"10.1186/s11689-024-09539-8","DOIUrl":"10.1186/s11689-024-09539-8","url":null,"abstract":"<p><strong>Background: </strong>Autism spectrum disorder (ASD) is currently diagnosed in approximately 1 in 44 children in the United States, based on a wide array of symptoms, including sensory dysfunction and abnormal language development. Boys are diagnosed ~ 3.8 times more frequently than girls. Auditory temporal processing is crucial for speech recognition and language development. Abnormal development of temporal processing may account for ASD language impairments. Sex differences in the development of temporal processing may underlie the differences in language outcomes in male and female children with ASD. To understand mechanisms of potential sex differences in temporal processing requires a preclinical model. However, there are no studies that have addressed sex differences in temporal processing across development in any animal model of ASD.</p><p><strong>Methods: </strong>To fill this major gap, we compared the development of auditory temporal processing in male and female wildtype (WT) and Fmr1 knock-out (KO) mice, a model of Fragile X Syndrome (FXS), a leading genetic cause of ASD-associated behaviors. Using epidural screw electrodes, we recorded auditory event related potentials (ERP) and auditory temporal processing with a gap-in-noise auditory steady state response (ASSR) paradigm at young (postnatal (p)21 and p30) and adult (p60) ages from both auditory and frontal cortices of awake, freely moving mice.</p><p><strong>Results: </strong>The results show that ERP amplitudes were enhanced in both sexes of Fmr1 KO mice across development compared to WT counterparts, with greater enhancement in adult female than adult male KO mice. Gap-ASSR deficits were seen in the frontal, but not auditory, cortex in early development (p21) in female KO mice. Unlike male KO mice, female KO mice show WT-like temporal processing at p30. There were no temporal processing deficits in the adult mice of both sexes.</p><p><strong>Conclusions: </strong>These results show a sex difference in the developmental trajectories of temporal processing and hypersensitive responses in Fmr1 KO mice. Male KO mice show slower maturation of temporal processing than females. Female KO mice show stronger hypersensitive responses than males later in development. The differences in maturation rates of temporal processing and hypersensitive responses during various critical periods of development may lead to sex differences in language function, arousal and anxiety in FXS.</p>","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"16 1","pages":"24"},"PeriodicalIF":4.9,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11077726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140892005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced lateralization of multiple functional brain networks in autistic males. 自闭症男性大脑多个功能网络的侧化减少
IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-05-08 DOI: 10.1186/s11689-024-09529-w
Madeline Peterson, Molly B D Prigge, Dorothea L Floris, Erin D Bigler, Brandon A Zielinski, Jace B King, Nicholas Lange, Andrew L Alexander, Janet E Lainhart, Jared A Nielsen

Background: Autism spectrum disorder has been linked to a variety of organizational and developmental deviations in the brain. One such organizational difference involves hemispheric lateralization, which may be localized to language-relevant regions of the brain or distributed more broadly.

Methods: In the present study, we estimated brain hemispheric lateralization in autism based on each participant's unique functional neuroanatomy rather than relying on group-averaged data. Additionally, we explored potential relationships between the lateralization of the language network and behavioral phenotypes including verbal ability, language delay, and autism symptom severity. We hypothesized that differences in hemispheric asymmetries in autism would be limited to the language network, with the alternative hypothesis of pervasive differences in lateralization. We tested this and other hypotheses by employing a cross-sectional dataset of 118 individuals (48 autistic, 70 neurotypical). Using resting-state fMRI, we generated individual network parcellations and estimated network asymmetries using a surface area-based approach. A series of multiple regressions were then used to compare network asymmetries for eight significantly lateralized networks between groups.

Results: We found significant group differences in lateralization for the left-lateralized Language (d = -0.89), right-lateralized Salience/Ventral Attention-A (d = 0.55), and right-lateralized Control-B (d = 0.51) networks, with the direction of these group differences indicating less asymmetry in autistic males. These differences were robust across different datasets from the same participants. Furthermore, we found that language delay stratified language lateralization, with the greatest group differences in language lateralization occurring between autistic males with language delay and neurotypical individuals.

Conclusions: These findings evidence a complex pattern of functional lateralization differences in autism, extending beyond the Language network to the Salience/Ventral Attention-A and Control-B networks, yet not encompassing all networks, indicating a selective divergence rather than a pervasive one. Moreover, we observed an association between Language network lateralization and language delay in autistic males.

背景:自闭症谱系障碍与大脑的各种组织和发育偏差有关。其中一种组织差异涉及大脑半球侧化,这种侧化可能局限于大脑中与语言相关的区域,也可能分布更广:在本研究中,我们根据每位受试者独特的功能神经解剖学而非群体平均数据来估计自闭症患者的大脑半球侧化。此外,我们还探讨了语言网络侧向化与行为表型(包括言语能力、语言延迟和自闭症症状严重程度)之间的潜在关系。我们假设自闭症患者大脑半球不对称的差异仅限于语言网络,而另一种假设是侧化差异普遍存在。我们利用 118 名患者(48 名自闭症患者,70 名神经畸形患者)的横断面数据集测试了这一假设和其他假设。通过静息态 fMRI,我们生成了个体网络细分,并使用基于表面积的方法估计了网络的不对称性。然后,我们使用一系列多元回归来比较八个显著侧化网络的组间网络不对称性:结果:我们发现,左侧化的语言网络(d = -0.89)、右侧化的 "注意力/中枢注意-A "网络(d = 0.55)和右侧化的 "控制-B "网络(d = 0.51)在侧向化方面存在明显的群体差异。这些差异在来自同一参与者的不同数据集中是稳健的。此外,我们还发现语言延迟使语言侧化分层,语言侧化的最大群体差异出现在患有语言延迟的男性自闭症患者和神经畸形患者之间:这些研究结果表明,自闭症患者的功能侧化差异模式非常复杂,从语言网络延伸到 "显著性"/"中枢注意"-A 和 "控制"-B 网络,但并不包括所有网络,这表明自闭症患者的功能侧化差异是选择性的,而不是普遍性的。此外,我们还观察到自闭症男性的语言网络侧化与语言延迟之间存在关联。
{"title":"Reduced lateralization of multiple functional brain networks in autistic males.","authors":"Madeline Peterson, Molly B D Prigge, Dorothea L Floris, Erin D Bigler, Brandon A Zielinski, Jace B King, Nicholas Lange, Andrew L Alexander, Janet E Lainhart, Jared A Nielsen","doi":"10.1186/s11689-024-09529-w","DOIUrl":"10.1186/s11689-024-09529-w","url":null,"abstract":"<p><strong>Background: </strong>Autism spectrum disorder has been linked to a variety of organizational and developmental deviations in the brain. One such organizational difference involves hemispheric lateralization, which may be localized to language-relevant regions of the brain or distributed more broadly.</p><p><strong>Methods: </strong>In the present study, we estimated brain hemispheric lateralization in autism based on each participant's unique functional neuroanatomy rather than relying on group-averaged data. Additionally, we explored potential relationships between the lateralization of the language network and behavioral phenotypes including verbal ability, language delay, and autism symptom severity. We hypothesized that differences in hemispheric asymmetries in autism would be limited to the language network, with the alternative hypothesis of pervasive differences in lateralization. We tested this and other hypotheses by employing a cross-sectional dataset of 118 individuals (48 autistic, 70 neurotypical). Using resting-state fMRI, we generated individual network parcellations and estimated network asymmetries using a surface area-based approach. A series of multiple regressions were then used to compare network asymmetries for eight significantly lateralized networks between groups.</p><p><strong>Results: </strong>We found significant group differences in lateralization for the left-lateralized Language (d = -0.89), right-lateralized Salience/Ventral Attention-A (d = 0.55), and right-lateralized Control-B (d = 0.51) networks, with the direction of these group differences indicating less asymmetry in autistic males. These differences were robust across different datasets from the same participants. Furthermore, we found that language delay stratified language lateralization, with the greatest group differences in language lateralization occurring between autistic males with language delay and neurotypical individuals.</p><p><strong>Conclusions: </strong>These findings evidence a complex pattern of functional lateralization differences in autism, extending beyond the Language network to the Salience/Ventral Attention-A and Control-B networks, yet not encompassing all networks, indicating a selective divergence rather than a pervasive one. Moreover, we observed an association between Language network lateralization and language delay in autistic males.</p>","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"16 1","pages":"23"},"PeriodicalIF":4.9,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11077748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study 与 PATH for PWS 自然史研究相比,接受二氮唑胆碱缓释片治疗的普拉德-威利综合征患者的行为变化
IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-04-26 DOI: 10.1186/s11689-024-09536-x
Theresa V. Strong, Jennifer L. Miller, Shawn E. McCandless, Evelien Gevers, Jack A. Yanovski, Lisa Matesevac, Jessica Bohonowych, Shaila Ballal, Kristen Yen, Patricia Hirano, Neil M. Cowen, Anish Bhatnagar
Prader-Willi syndrome (PWS) is a rare neurobehavioral-metabolic disease caused by the lack of paternally expressed genes in the chromosome 15q11-q13 region, characterized by hypotonia, neurocognitive problems, behavioral difficulties, endocrinopathies, and hyperphagia resulting in severe obesity if energy intake is not controlled. Diazoxide choline extended-release (DCCR) tablets have previously been evaluated for their effects on hyperphagia and other behavioral complications of people with PWS in a Phase 3 placebo-controlled study of participants with PWS, age 4 and older with hyperphagia (C601) and in an open label extension study, C602. To better understand the longer-term impact of DCCR, a cohort from PATH for PWS, a natural history study that enrolled participants with PWS age 5 and older, who met the C601 age, weight and baseline hyperphagia inclusion criteria and had 2 hyperphagia assessments ≥ 6 months apart, were compared to the C601/C602 cohort. Hyperphagia was measured using the Hyperphagia Questionnaire for Clinical Trials (HQ-CT, range 0–36). The primary analysis used observed values with no explicit imputation of missing data. A sensitivity analysis was conducted in which all missing HQ-CT assessments in the C601/C602 cohort were assigned the highest possible value (36), representing the worst-case scenario. Other behavioral changes were assessed using the Prader-Willi Syndrome Profile questionnaire (PWSP). Relative to the PATH for PWS natural history study cohort, the DCCR-treated C601/C602 cohort showed significant improvements in HQ-CT score at 26 weeks (LSmean [SE] -8.3 [0.75] vs. -2.5 [0.43], p < 0.001) and 52 weeks (LSmean [SE] -9.2 [0.77] vs. -3.4 [0.47], p < 0.001). The comparison between the cohorts remained significant in the worst-case imputation sensitivity analysis. There were also significant improvements in all domains of the PWSP at 26 weeks (all p < 0.001) and 52 weeks (all p ≤ 0.003) for C601/C602 participants compared to the PATH for PWS participants. Long-term administration of DCCR to people with PWS resulted in changes in hyperphagia and other behavioral complications of PWS that are distinct from the natural history of the syndrome as exemplified by the cohort from PATH for PWS. The combined effects of administration of DCCR should reduce the burden of the syndrome on the patient, caregivers and their families, and thereby may benefit people with PWS and their families. Clinical study C601 was originally registered on ClinicalTrials.gov on February 22, 2018 (NCT03440814). Clinical study C602 was originally registered on ClinicalTrials.gov on October 22, 2018 (NCT03714373). PATH for PWS was originally registered on ClinicalTrials.gov on October 24, 2018 (NCT03718416).
普拉德-威利综合征(Prader-Willi Syndrome,PWS)是一种罕见的神经行为代谢疾病,由染色体 15q11-q13 区域缺乏父系表达基因引起,其特征是肌张力低下、神经认知问题、行为障碍、内分泌病变以及多食,如果不控制能量摄入,会导致严重肥胖。重氮胆碱缓释片(DCCR)曾在一项针对 4 岁及以上患有多食症的 PWS 患者的 3 期安慰剂对照研究(C601)和一项开放标签扩展研究(C602)中评估了其对 PWS 患者多食症和其他行为并发症的影响。为了更好地了解 DCCR 的长期影响,我们将 PATH for PWS 的一组患者与 C601/C602 的患者进行了比较,PATH for PWS 是一项自然史研究,招募了 5 岁及以上的 PWS 患者,这些患者符合 C601 的年龄、体重和基线多食症纳入标准,并且两次多食症评估相隔时间≥ 6 个月。多食症使用临床试验多食症问卷(HQ-CT,范围 0-36)进行测量。主要分析采用观察值,未对缺失数据进行明确估算。在敏感性分析中,C601/C602队列中所有缺失的HQ-CT评估值都被赋予了可能的最高值(36),这代表了最坏的情况。其他行为变化采用普拉德-威利综合征档案问卷(PWSP)进行评估。与 PATH for PWS 自然史研究队列相比,DCCR 治疗的 C601/C602 队列在 26 周(LSmean [SE] -8.3 [0.75] vs. -2.5 [0.43],p < 0.001)和 52 周(LSmean [SE] -9.2 [0.77] vs. -3.4 [0.47],p < 0.001)的 HQ-CT 评分有显著改善。在最坏情况估算敏感性分析中,各组间的比较仍然显著。与PWS参与者的PATH相比,C601/C602参与者在26周(所有P<0.001)和52周(所有P≤0.003)的PWSP所有领域都有明显改善。对PWS患者长期服用DCCR会导致吞咽功能亢进和PWS的其他行为并发症发生变化,这与PATH治疗PWS队列中的综合征自然病史不同。服用 DCCR 的综合效果应能减轻该综合征给患者、护理人员及其家人带来的负担,从而使 PWS 患者及其家人受益。临床研究C601最初于2018年2月22日在ClinicalTrials.gov上注册(NCT03440814)。临床研究C602最初于2018年10月22日在ClinicalTrials.gov上注册(NCT03714373)。PATH治疗PWS最初于2018年10月24日在ClinicalTrials.gov上注册(NCT03718416)。
{"title":"Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study","authors":"Theresa V. Strong, Jennifer L. Miller, Shawn E. McCandless, Evelien Gevers, Jack A. Yanovski, Lisa Matesevac, Jessica Bohonowych, Shaila Ballal, Kristen Yen, Patricia Hirano, Neil M. Cowen, Anish Bhatnagar","doi":"10.1186/s11689-024-09536-x","DOIUrl":"https://doi.org/10.1186/s11689-024-09536-x","url":null,"abstract":"Prader-Willi syndrome (PWS) is a rare neurobehavioral-metabolic disease caused by the lack of paternally expressed genes in the chromosome 15q11-q13 region, characterized by hypotonia, neurocognitive problems, behavioral difficulties, endocrinopathies, and hyperphagia resulting in severe obesity if energy intake is not controlled. Diazoxide choline extended-release (DCCR) tablets have previously been evaluated for their effects on hyperphagia and other behavioral complications of people with PWS in a Phase 3 placebo-controlled study of participants with PWS, age 4 and older with hyperphagia (C601) and in an open label extension study, C602. To better understand the longer-term impact of DCCR, a cohort from PATH for PWS, a natural history study that enrolled participants with PWS age 5 and older, who met the C601 age, weight and baseline hyperphagia inclusion criteria and had 2 hyperphagia assessments ≥ 6 months apart, were compared to the C601/C602 cohort. Hyperphagia was measured using the Hyperphagia Questionnaire for Clinical Trials (HQ-CT, range 0–36). The primary analysis used observed values with no explicit imputation of missing data. A sensitivity analysis was conducted in which all missing HQ-CT assessments in the C601/C602 cohort were assigned the highest possible value (36), representing the worst-case scenario. Other behavioral changes were assessed using the Prader-Willi Syndrome Profile questionnaire (PWSP). Relative to the PATH for PWS natural history study cohort, the DCCR-treated C601/C602 cohort showed significant improvements in HQ-CT score at 26 weeks (LSmean [SE] -8.3 [0.75] vs. -2.5 [0.43], p < 0.001) and 52 weeks (LSmean [SE] -9.2 [0.77] vs. -3.4 [0.47], p < 0.001). The comparison between the cohorts remained significant in the worst-case imputation sensitivity analysis. There were also significant improvements in all domains of the PWSP at 26 weeks (all p < 0.001) and 52 weeks (all p ≤ 0.003) for C601/C602 participants compared to the PATH for PWS participants. Long-term administration of DCCR to people with PWS resulted in changes in hyperphagia and other behavioral complications of PWS that are distinct from the natural history of the syndrome as exemplified by the cohort from PATH for PWS. The combined effects of administration of DCCR should reduce the burden of the syndrome on the patient, caregivers and their families, and thereby may benefit people with PWS and their families. Clinical study C601 was originally registered on ClinicalTrials.gov on February 22, 2018 (NCT03440814). Clinical study C602 was originally registered on ClinicalTrials.gov on October 22, 2018 (NCT03714373). PATH for PWS was originally registered on ClinicalTrials.gov on October 24, 2018 (NCT03718416).","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"155 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140802059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An overview of current advances in perinatal alcohol exposure and pathogenesis of fetal alcohol spectrum disorders 围产期酒精暴露和胎儿酒精谱系障碍发病机制的最新进展概述
IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-04-20 DOI: 10.1186/s11689-024-09537-w
Xingdong Zeng, Yongle Cai, Mengyan Wu, Haonan Chen, Miao Sun, Hao Yang
The adverse use of alcohol is a serious global public health problem. Maternal alcohol consumption during pregnancy usually causes prenatal alcohol exposure (PAE) in the developing fetus, leading to a spectrum of disorders known as fetal alcohol spectrum disorders (FASD) and even fetal alcohol syndrome (FAS) throughout the lifelong sufferers. The prevalence of FASD is approximately 7.7 per 1,000 worldwide, and is even higher in developed regions. Generally, Ethanol in alcoholic beverages can impair embryonic neurological development through multiple pathways leading to FASD. Among them, the leading mechanism of FASDs is attributed to ethanol-induced neuroinflammatory damage to the central nervous system (CNS). Although the underlying molecular mechanisms remain unclear, the remaining multiple pathological mechanisms is likely due to the neurotoxic damage of ethanol and the resultant neuronal loss. Regardless of the molecular pathway, the ultimate outcome of the developing CNS exposed to ethanol is almost always the destruction and apoptosis of neurons, which leads to the reduction of neurons and further the development of FASD. In this review, we systematically summarize the current research progress on the pathogenesis of FASD, which hopefully provides new insights into differential early diagnosis, treatment and prevention for patents with FASD.
酗酒是一个严重的全球性公共卫生问题。母亲在怀孕期间饮酒通常会导致发育中的胎儿出现产前酒精暴露(PAE),从而导致一系列疾病,即胎儿酒精谱系障碍(FASD),甚至导致胎儿酒精综合症(FAS),患者终生受其折磨。全世界 FASD 的发病率约为 7.7‰,发达地区的发病率更高。一般来说,酒精饮料中的乙醇会通过多种途径损害胚胎神经系统的发育,从而导致 FASD。其中,导致 FASD 的主要机制是乙醇引起的中枢神经系统(CNS)神经炎症损伤。尽管潜在的分子机制尚不清楚,但其余的多种病理机制很可能是由于乙醇的神经毒性损伤以及由此导致的神经元损失。无论分子途径如何,暴露于乙醇的发育中中枢神经系统的最终结果几乎总是神经元的破坏和凋亡,从而导致神经元的减少,并进一步发展为 FASD。在这篇综述中,我们系统地总结了目前有关 FASD 发病机制的研究进展,希望能为 FASD 患者的早期鉴别诊断、治疗和预防提供新的思路。
{"title":"An overview of current advances in perinatal alcohol exposure and pathogenesis of fetal alcohol spectrum disorders","authors":"Xingdong Zeng, Yongle Cai, Mengyan Wu, Haonan Chen, Miao Sun, Hao Yang","doi":"10.1186/s11689-024-09537-w","DOIUrl":"https://doi.org/10.1186/s11689-024-09537-w","url":null,"abstract":"The adverse use of alcohol is a serious global public health problem. Maternal alcohol consumption during pregnancy usually causes prenatal alcohol exposure (PAE) in the developing fetus, leading to a spectrum of disorders known as fetal alcohol spectrum disorders (FASD) and even fetal alcohol syndrome (FAS) throughout the lifelong sufferers. The prevalence of FASD is approximately 7.7 per 1,000 worldwide, and is even higher in developed regions. Generally, Ethanol in alcoholic beverages can impair embryonic neurological development through multiple pathways leading to FASD. Among them, the leading mechanism of FASDs is attributed to ethanol-induced neuroinflammatory damage to the central nervous system (CNS). Although the underlying molecular mechanisms remain unclear, the remaining multiple pathological mechanisms is likely due to the neurotoxic damage of ethanol and the resultant neuronal loss. Regardless of the molecular pathway, the ultimate outcome of the developing CNS exposed to ethanol is almost always the destruction and apoptosis of neurons, which leads to the reduction of neurons and further the development of FASD. In this review, we systematically summarize the current research progress on the pathogenesis of FASD, which hopefully provides new insights into differential early diagnosis, treatment and prevention for patents with FASD.","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"4 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2024-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140625177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurobehavioral outcomes of neonatal asymptomatic congenital cytomegalovirus infection at 12-months 新生儿无症状先天性巨细胞病毒感染 12 个月后的神经行为结果
IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-04-18 DOI: 10.1186/s11689-024-09533-0
Sally M. Stoyell, Jed T. Elison, Emily Graupmann, Neely C. Miller, Jessica Emerick, Elizabeth Ramey, Kristen Sandness, Mark R. Schleiss, Erin A. Osterholm
Congenital cytomegalovirus (cCMV) is the most common congenital viral infection in the United States. Symptomatic infections can cause severe hearing loss and neurological disability, although ~ 90% of cCMV infections are asymptomatic at birth. Despite its prevalence, the long-term neurobehavioral risks of asymptomatic cCMV infections are not fully understood. The objective of this work was to evaluate for potential long-term neurobehavioral sequelae in infants with asymptomatic cCMV. Infants with cCMV were identified from a universal newborn cCMV screening study in a metropolitan area in the midwestern United States. Asymptomatic infants with cCMV were enrolled in a longitudinal neurodevelopmental study (N = 29). Age- and sex-matched healthy control infants (N = 193) were identified from the Baby Connectome Project (BCP), a longitudinal study of brain and behavioral development. The BCP sample supplemented an additional group of healthy control infants (N = 30), recruited from the same participant registry as the BCP specifically for comparison with infants with asymptomatic cCMV. Neurobehavioral assessments and parent questionnaires, including the Mullen Scales of Early Learning, the Repetitive Behavior Scales for Early Childhood (RBS-EC), and the Infant Toddler Social Emotional Assessment (ITSEA) were administered at 12 months of age. Neurobehavioral scores were compared between infants with asymptomatic cCMV and all identified healthy control infants. Infants with asymptomatic cCMV performed equivalently compared to healthy control infants on the neurobehavioral measures tested at 12 months of age. These results indicate that at 12 months of age, infants with asymptomatic cCMV are not statistically different from controls in a number of neurobehavioral domains. Although follow-up is ongoing, these observations provide reassurance about neurobehavioral outcomes for infants with asymptomatic cCMV and inform the ongoing discussion around universal screening. Additional follow-up will be necessary to understand the longer-term outcomes of these children.
先天性巨细胞病毒(cCMV)是美国最常见的先天性病毒感染。无症状感染可导致严重听力损失和神经系统残疾,但约 90% 的 cCMV 感染在出生时无症状。尽管该病很普遍,但无症状 cCMV 感染对神经行为的长期风险尚未完全明了。这项研究的目的是评估无症状 cCMV 感染婴儿的潜在长期神经行为后遗症。在美国中西部一个大都会地区进行的新生儿 cCMV 普遍筛查研究中,发现了感染 cCMV 的婴儿。患有 cCMV 的无症状婴儿参加了一项纵向神经发育研究(N = 29)。年龄和性别匹配的健康对照组婴儿(N = 193)是从婴儿连接组项目(BCP)中确定的,该项目是一项关于大脑和行为发育的纵向研究。BCP 样本补充了另外一组健康对照婴儿(N = 30),这组婴儿是从与 BCP 相同的参与者登记处招募的,专门用于与无症状 cCMV 婴儿进行比较。在婴儿 12 个月大时进行神经行为评估和家长问卷调查,包括穆伦早期学习量表(Mullen Scales of Early Learning)、幼儿重复行为量表(RBS-EC)和婴幼儿社会情感评估(ITSEA)。将患有无症状 cCMV 的婴儿与所有已确定的健康对照组婴儿的神经行为评分进行比较。与健康对照组婴儿相比,无症状 cCMV 患儿在 12 个月大时的神经行为测试中表现相当。这些结果表明,12 个月大时,患有无症状 cCMV 的婴儿在一些神经行为领域与对照组婴儿没有统计学差异。虽然后续研究仍在进行中,但这些观察结果为患有无症状 cCMV 的婴儿的神经行为结果提供了保证,并为正在进行的有关普遍筛查的讨论提供了信息。要了解这些儿童的长期结果,还需要进行更多的随访。
{"title":"Neurobehavioral outcomes of neonatal asymptomatic congenital cytomegalovirus infection at 12-months","authors":"Sally M. Stoyell, Jed T. Elison, Emily Graupmann, Neely C. Miller, Jessica Emerick, Elizabeth Ramey, Kristen Sandness, Mark R. Schleiss, Erin A. Osterholm","doi":"10.1186/s11689-024-09533-0","DOIUrl":"https://doi.org/10.1186/s11689-024-09533-0","url":null,"abstract":"Congenital cytomegalovirus (cCMV) is the most common congenital viral infection in the United States. Symptomatic infections can cause severe hearing loss and neurological disability, although ~ 90% of cCMV infections are asymptomatic at birth. Despite its prevalence, the long-term neurobehavioral risks of asymptomatic cCMV infections are not fully understood. The objective of this work was to evaluate for potential long-term neurobehavioral sequelae in infants with asymptomatic cCMV. Infants with cCMV were identified from a universal newborn cCMV screening study in a metropolitan area in the midwestern United States. Asymptomatic infants with cCMV were enrolled in a longitudinal neurodevelopmental study (N = 29). Age- and sex-matched healthy control infants (N = 193) were identified from the Baby Connectome Project (BCP), a longitudinal study of brain and behavioral development. The BCP sample supplemented an additional group of healthy control infants (N = 30), recruited from the same participant registry as the BCP specifically for comparison with infants with asymptomatic cCMV. Neurobehavioral assessments and parent questionnaires, including the Mullen Scales of Early Learning, the Repetitive Behavior Scales for Early Childhood (RBS-EC), and the Infant Toddler Social Emotional Assessment (ITSEA) were administered at 12 months of age. Neurobehavioral scores were compared between infants with asymptomatic cCMV and all identified healthy control infants. Infants with asymptomatic cCMV performed equivalently compared to healthy control infants on the neurobehavioral measures tested at 12 months of age. These results indicate that at 12 months of age, infants with asymptomatic cCMV are not statistically different from controls in a number of neurobehavioral domains. Although follow-up is ongoing, these observations provide reassurance about neurobehavioral outcomes for infants with asymptomatic cCMV and inform the ongoing discussion around universal screening. Additional follow-up will be necessary to understand the longer-term outcomes of these children.","PeriodicalId":16530,"journal":{"name":"Journal of Neurodevelopmental Disorders","volume":"16 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140612202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Neurodevelopmental Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1